Institute of Cancer Research-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2022

  1. Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial

    Frontiers in Oncology, Vol. 12